Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01268111 · ClinicalTrials.gov registry record · Phase 1
Effect of Vitamin D Replacement on Insulin Sensitivity
A Phase 1 study, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT01268111 is a Phase 1 study that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 12 participants.
The verdict
NCT01268111, a Phase 1 study, has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
Healthy subjects with low Vitamin D levels will be randomly assigned to either Vitamin D replacement or placebo for a period of 8 weeks. Insulin sensitivity will be measured before and after the intervention, and the changes will be compared between the two groups. This will help us understand if Vitamin D replacement improves insulin sensitivity. Serum Retinol Binding Protein 4 levels will also be measured to see if changes in insulin sensitivity are mediated by RBP4.
Interventions
- DRUG Placebo
- DRUG Ergocalciferols
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-01 |
| Est. Completion | 2012-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01268111
The ClinicalTrials.gov registry entry for NCT01268111 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01268111 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01268111 about?
NCT01268111 is a clinical study titled "Effect of Vitamin D Replacement on Insulin Sensitivity". Healthy subjects with low Vitamin D levels will be randomly assigned to either Vitamin D replacement or placebo for a period of 8 weeks. Insulin sensitivity will be measured before and after the intervention, and the changes will be compared between the two groups. This will help us understand if Vi...
What is the current status of trial NCT01268111?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2011-01. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01268111?
The interventions under investigation include: Placebo (DRUG), Ergocalciferols (DRUG).
Who is sponsoring clinical trial NCT01268111?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.